For a second time recently, ISDA have blasted a publication for making a mess of reporting on the market, and putting out a confused message on OTC products. The New York Times gets both barrels this time, original item here.

Their main complaint is that MF Global was laid low via the Repo market, and their holding of debt to maturity, and this time, nothing to do with OTC derivatives.